A case report demonstrates oclacitinib's effectiveness as a corticosteroid-sparing agent for pemphigus foliaceus, suggesting a new treatment avenue.
however, biopsy may be delayed for financial or logistical reasons, and treatment is sometimes started on the basis of clinical appearance and cytology alone, which may later render histopathology non-diagnostic.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: